PGRN Hub
  • Home
  • What is PGRN?
  • Members
    • Join
    • Members >
      • Member Research Interests
      • Members List
      • Members Directory
    • Apply for a Webpage
    • Research Pages >
      • African American Pharmacogenomics
      • Clinical Implementation of PGx
      • I-PICC: Integrating Pharmacogenetics in Clinical Care
      • Genetics of Israeli Populations (NLGIP)
      • GeT-RM PGx
      • Metformin PGx
      • MT-targeting agents
      • PEGASUS: Personalizing Emergency/Acute Therapeutics Utilizing Systems Biology
      • PGx of AIWG
      • PGx of Chemotherapeutic Toxicities
      • PGx of Statin Therapy
      • Precision Medicine In Leukemia
      • Predicting Drug Action
      • ...More Pages Coming Soon
    • Partner PGx Organizations >
      • UKPSMN
      • UPGx
    • Communities >
      • MetGen
    • Leadership
  • Data & Tools
    • GWAS Statistics >
      • RIKEN GWAS Statistics
    • Tools
  • PGRN Resources
    • Forum / Community
    • Clinical Implementation
    • Functional Pharmacogenes
    • PGRN Hub
    • PGRN-PiLS Resource
    • PGRN-RIKEN >
      • RIKEN Publications
      • RIKEN Investigators
      • RIKEN Projects
    • PharmGKB
    • PharmVar
    • RPGEH
  • News
    • Event Calendar
    • PGX News
    • Featured Investigators
    • PGRN Recorded Talks
    • All PGRN Publications
  • Meetings
    • Monthly Member RIPS
    • All-Members Calls
    • Upcoming PGRN Meetings >
      • Poster Session at ASCPT 2020
    • Past PGRN Meetings >
      • ASHG 2019
      • CPIC® Meeting 2019
      • Poster Session at ASCPT 2019
      • ASHG 2018
      • ASHG 2017
      • CPIC® Meeting 2017
      • ASHG 2016
      • Annual PGRN meeting at ASCPT 2016
      • 2015 PGRN All PIs Retreat
    • Other PGx Meetings

Featured PGRN Investigators

Collen Masimirembwa, DPhil, PhD

2/1/2018

 
Collen Masimirembwa is the founding President and Chief Scientific Officer of the African Institute of Biomedical Science and Technology, AiBST, www.aibst.com. He previously worked for AstraZeneca Pharmaceutical Company in Sweden for 10 years as a Principal Scientist in DMK & Bioanalytical Chemistry. With support from various funding organizations (ISP, EDCTP, CDC, TWAS, WHO, NIH, NEPAD/SANBIO), companies (AstraZeneca, Novartis, Merck) and colleagues in academia and industry, he has established AiBST research laboratories in Zimbabwe and South Africa that focus on drugs and diagnostics innovation. He is Honorary Professor of Clinical Pharmacology at the University of Cape Town and of Health Sciences at the University of KwaZulu Natal in South Africa. He is also a Fellow of the Zimbabwe Academy of Sciences and the African Academy of Sciences.
Picture
President and Chief Scientific Officer
​African Institute of Biomedical Science and Technology
collen.masimirembwa@aibst.com

More Information 
Collen Masimirembwa is a pioneer of pharmacogenetics research in Africa and continues to champion its development to clinical applications. He conducted the first molecular genetic studies in African populations in the early 90s leading to the discovery of the African specific CYP2D6 genetic variant, CYP2D6*17. Over the past 25 years he has endeavored to integrated pharmacogenetics in the drug discovery and development value chain with a particular interest in understanding the genomic diversity of African populations and its implications for drug safety and efficacy. He has published over 90 original papers on the metabolism & pharmacokinetics of antiparasitic drugs and on the population genetic polymorphism of ADME genes in Africa. This has allowed him to combine pharmacokinetics modeling & simulation and molecular structural & functional studies of genetic variation of ADME to bridge basic genetic polymorphism research to clinical applications. This research has led to the award-winning pharmacogenetics test and dosing algorithm for the safe use of the antiretroviral drug, efavirenz (EFV). The product, GeneDoseÒ-EFV is now under commercial development.
 
To build capacity for pharmacogenomics research in Africa Collen has used his institute and extensive international network of collaborators to train Masters and PhD students in Africa, who are, in their various settings conducting basic and translational pharmacogenetics research. This has culminated in an EDCTP (European and Developing Countries Clinical Trial Partnership) training grant to initiate a 2-year Master’s degree in Genomic Medicine and Molecular Diagnostics, whose first intake will be in January 2019. Towards this, Collen is appealing for support from the international pharmacogenetics community to assist with mentorship and opportunities for research project attachment for students of this MSc program through AiBST’s Virtual Global Faculty program (contact him at collenmasimirembwa@yahoo.com).

    Author

    PGRN Hub & the Featured Investigator

    Archives

    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    May 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015

    Categories

    All

    RSS Feed

Join

Contact Us

Feedback

Picture
  • Home
  • What is PGRN?
  • Members
    • Join
    • Members >
      • Member Research Interests
      • Members List
      • Members Directory
    • Apply for a Webpage
    • Research Pages >
      • African American Pharmacogenomics
      • Clinical Implementation of PGx
      • I-PICC: Integrating Pharmacogenetics in Clinical Care
      • Genetics of Israeli Populations (NLGIP)
      • GeT-RM PGx
      • Metformin PGx
      • MT-targeting agents
      • PEGASUS: Personalizing Emergency/Acute Therapeutics Utilizing Systems Biology
      • PGx of AIWG
      • PGx of Chemotherapeutic Toxicities
      • PGx of Statin Therapy
      • Precision Medicine In Leukemia
      • Predicting Drug Action
      • ...More Pages Coming Soon
    • Partner PGx Organizations >
      • UKPSMN
      • UPGx
    • Communities >
      • MetGen
    • Leadership
  • Data & Tools
    • GWAS Statistics >
      • RIKEN GWAS Statistics
    • Tools
  • PGRN Resources
    • Forum / Community
    • Clinical Implementation
    • Functional Pharmacogenes
    • PGRN Hub
    • PGRN-PiLS Resource
    • PGRN-RIKEN >
      • RIKEN Publications
      • RIKEN Investigators
      • RIKEN Projects
    • PharmGKB
    • PharmVar
    • RPGEH
  • News
    • Event Calendar
    • PGX News
    • Featured Investigators
    • PGRN Recorded Talks
    • All PGRN Publications
  • Meetings
    • Monthly Member RIPS
    • All-Members Calls
    • Upcoming PGRN Meetings >
      • Poster Session at ASCPT 2020
    • Past PGRN Meetings >
      • ASHG 2019
      • CPIC® Meeting 2019
      • Poster Session at ASCPT 2019
      • ASHG 2018
      • ASHG 2017
      • CPIC® Meeting 2017
      • ASHG 2016
      • Annual PGRN meeting at ASCPT 2016
      • 2015 PGRN All PIs Retreat
    • Other PGx Meetings